We are live on
!
Find out more
Ginkgo Bioworks
DNA
DNA
315 hedge funds and large institutions have $2.25B invested in Ginkgo Bioworks in 2023 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 121 increasing their positions, 62 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
95% more repeat investments, than reductions
Existing positions increased: 121 | Existing positions reduced: 62
49% more capital invested
Capital invested by funds: $1.51B → $2.25B (+$736M)
5% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 41
1% more funds holding
Funds holding: 313 → 315 (+2)
0.1% more ownership
Funds ownership: 1.81% → 1.91% (+0.1%)
23% less call options, than puts
Call options by funds: $5.42M | Put options by funds: $7.03M
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
315
Holders Change
+2
Holders Change %
+0.64%
% of All Funds
4.95%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
43
Increased
121
Reduced
62
Closed
41
Calls
$5.42M
Puts
$7.03M
Net Calls
-$1.61M
Net Calls Change
-$1.96M
Top Buyers
| 1 |
BlackRock
New York
|
+$26M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$25.8M |
| 3 |
NAMA
Nikko Asset Management Americas
New York
|
+$12.1M |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$12.1M |
| 5 |
Millennium Management
New York
|
+$10.8M |
